Using absolute prostate-specific antigen (PSA) thresholds to make decisions about diagnostic testing and biopsies remains controversial (Journal Watch Top Story Dec 31 2004), but PSA velocity (the ...
We need better ways to determine which prostate-specific antigen (PSA)-detected localized prostate cancers are most likely to progress. The rate at which the PSA level rises (i.e., PSA velocity) prior ...
We conducted a systematic review of studies published before March 2007 in which a PSA dynamic (velocity or doubling time) was calculated in patients before definitive treatment, a subsequent event ...
Arnhem, November 2009 – The November issue of European Urology, the official journal of the European Association of Urology, features an article focussing on prostate specific antigen (PSA) velocity ...
Serum PSA values >4.0 ng/ml are routinely used to select patients for prostate biopsy, although this approach misses some early-stage cancers. Some researchers advocate dropping the PSA threshold to 2 ...
Elevated serum prostate-specific antigen (PSA) levels can indicate the presence of prostate cancer, although PSA levels are also elevated in some nonmalignant conditions, which affects the reliability ...
A phase IIb trial of docetaxel concurrent with radiotherapy plus hormotherapy versus radio hormonotherapy in high-risk localized prostate cancer (QRT SOGUG trial): Preliminary report for design, ...
CHICAGO (Reuters) - A sudden spike in blood levels of prostate specific antigen, or PSA, is not an accurate way to predict prostate cancer, and testing for such changes can lead to overtreatment, U.S.
The most significant single predictor of aggressive prostate cancer is an elevated rate of increase in prostate specific antigen (PSA) levels, according to a new study. Published in the July 1, 2007 ...
PSA blood test Compared with absolute PSA, PSA velocity associated more with increased likelihood of progression among men on active surveillance for prostate cancer. PSA velocity (PSAV) is associated ...
This story is free to read because readers choose to support LAist. If you find value in independent local reporting, make a donation to power our newsroom today. Listen 0:00 Jim, a 57-year-old Boston ...
To the Editor: There are some basic methodologic flaws in the work by D'Amico et al. (July 8 issue). 1 In their multivariate analyses, the prostate-specific antigen (PSA) velocity was modeled as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results